GB9007378D0 - Detoxification using micro-organisms - Google Patents

Detoxification using micro-organisms

Info

Publication number
GB9007378D0
GB9007378D0 GB909007378A GB9007378A GB9007378D0 GB 9007378 D0 GB9007378 D0 GB 9007378D0 GB 909007378 A GB909007378 A GB 909007378A GB 9007378 A GB9007378 A GB 9007378A GB 9007378 D0 GB9007378 D0 GB 9007378D0
Authority
GB
United Kingdom
Prior art keywords
micro
organism
organisms
bloodstream
toxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909007378A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bio Separation Ltd
Original Assignee
Bio Separation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Separation Ltd filed Critical Bio Separation Ltd
Priority to GB909007378A priority Critical patent/GB9007378D0/en
Publication of GB9007378D0 publication Critical patent/GB9007378D0/en
Priority to GB9106663A priority patent/GB2243158A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Abstract

A pharmaceutical composition comprising an anaerobic micro-organism and a physiologically acceptable inorganic compound capable of being converted by the micro-organism into an insoluble product which is deposited on the micro-organism and grows to form a cluster; the cluster being capable of adsorbing toxins. Preferably the micro-organism is Desulphovibrio. Micro-organisms and compounds such as iron (II) solphate as hereinbefore described for use in a therapeutic method for removal of a toxin from the human or animal gut or bloodstream and for use in the manufacture of a medicament for therapy by removal of a toxin from the human or animal gut or bloodstream.
GB909007378A 1990-04-02 1990-04-02 Detoxification using micro-organisms Pending GB9007378D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB909007378A GB9007378D0 (en) 1990-04-02 1990-04-02 Detoxification using micro-organisms
GB9106663A GB2243158A (en) 1990-04-02 1991-03-28 Detoxification using micro-organisms

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909007378A GB9007378D0 (en) 1990-04-02 1990-04-02 Detoxification using micro-organisms

Publications (1)

Publication Number Publication Date
GB9007378D0 true GB9007378D0 (en) 1990-05-30

Family

ID=10673723

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909007378A Pending GB9007378D0 (en) 1990-04-02 1990-04-02 Detoxification using micro-organisms
GB9106663A Withdrawn GB2243158A (en) 1990-04-02 1991-03-28 Detoxification using micro-organisms

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9106663A Withdrawn GB2243158A (en) 1990-04-02 1991-03-28 Detoxification using micro-organisms

Country Status (1)

Country Link
GB (2) GB9007378D0 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4780238A (en) * 1983-08-25 1988-10-25 The United States Of America As Represented By The United States Department Of Energy Natural chelating agents for radionuclide decorporation

Also Published As

Publication number Publication date
GB9106663D0 (en) 1991-05-15
GB2243158A (en) 1991-10-23

Similar Documents

Publication Publication Date Title
MY113059A (en) Controlled-release dosage forms of azithromycin
AU3040995A (en) Treatment of autoimmune diseases by oral administration of autoantigens
ES2077530A1 (en) Pharmaceutical products for curing tumorous diseases and process for preparing same
EP0377520A3 (en) Use of nicotine for the manufacture of a kit for the treatment of conditions susceptible to said treatment
SG158731A1 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
EP0734723A4 (en) Therapeutic composition for hyperparathyroidism of patient subjected to artificial dialysis
AU1146295A (en) Products containing G-CSF and TNF binding protein
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
JP2002523437A5 (en)
GB9106663D0 (en) Detoxification using micro-organisms
WO1996030016A3 (en) Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases
NZ307601A (en) Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
EP0286802A3 (en) Use of ofloxacin in treating or preventing locally periodontal disease
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
MD197G2 (en) Preparation and method for hypogalactia treatment
DE3473457D1 (en) A new compound, fr-900451, production and use thereof
UA28288A (en) Method for treatment of schizophrenia
UA10093A (en) Method for treatment of colon diseases
UA7190A (en) Method for treating pyo-inflammatory processes in lungs
UA13880A (en) Method for prevention of postoperative complications
MY104932A (en) Immunomodulatory azaspiranes
RU96122672A (en) ECHINAMAX. METHOD OF TREATMENT OF ASTHENIC CONDITIONS IN PHYSIOGENIC DISADAPTATIONS